Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study.

Pia Montanucci(University of Perugia), Riccardo Calafiore(University of Perugia), Daniela Francisci(University of Perugia), Teresa Pescara(University of Perugia), Giuseppe Basta(University of Perugia), Alessia Greco(University of Perugia)
PubMed
January 1, 2021
Cited by 5

Related Papers

Cell encapsulation: Promise and progress
|Nature Medicine|2003|592
History, challenges and perspectives of cell microencapsulation
|Trends in biotechnology|2003|346
Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes
|Diabetes Care|2006|321
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine
|Gastroenterology|2015|256
Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet Allografts
|Diabetes Care|2011|230